BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 11986095)

  • 1. Clinicopathologic features and behavior of cutaneous eyelid melanoma.
    Vaziri M; Buffam FV; Martinka M; Oryschak A; Dhaliwal H; White VA
    Ophthalmology; 2002 May; 109(5):901-8. PubMed ID: 11986095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
    Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
    Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for survival in malignant melanoma of the eyelid skin.
    Esmaeli B; Wang B; Deavers M; Gillenwater A; Goepfert H; Diaz E; Eicher S
    Ophthalmic Plast Reconstr Surg; 2000 Jul; 16(4):250-7. PubMed ID: 10923972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palpebral cutaneous melanomas: a review of 17 cases from a tertiary center.
    Tas F; Erturk K
    Int J Dermatol; 2019 Jan; 58(1):75-79. PubMed ID: 30171604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. The consequences of a reclassification of the original group of lentigo maligna melanomas.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1979 Jul; 87A(4):255-60. PubMed ID: 474127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous melanoma of the eyelid. Clinicopathologic features.
    Grossniklaus HE; McLean IW
    Ophthalmology; 1991 Dec; 98(12):1867-73. PubMed ID: 1775323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and outcomes of malignant melanoma of the eyelid: a review of 29 cases in Australia.
    Chan FM; O'Donnell BA; Whitehead K; Ryman W; Sullivan TJ
    Ophthalmology; 2007 Jan; 114(1):187-92. PubMed ID: 17140665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Margins of excision and prognostic factors for cutaneous eyelid melanomas.
    Harish V; Bond JS; Scolyer RA; Haydu LE; Saw RP; Quinn MJ; Benger RS; Uren RF; Stretch JR; Shannon KF; Thompson JF
    J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1066-73. PubMed ID: 23688975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of periocular cutaneous melanoma with a staged excision technique and permanent sections the square procedure.
    Demirci H; Johnson TM; Frueh BR; Musch DC; Fullen DR; Nelson CC
    Ophthalmology; 2008 Dec; 115(12):2295-2300.e3. PubMed ID: 18692248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
    MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous melanomas of the eyelid.
    Boulos PR; Rubin PA
    Semin Ophthalmol; 2006; 21(3):195-206. PubMed ID: 16912018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant melanoma: depth of invasion and histologic typing].
    Hermanek P; Hornstein OP; Tonak J; Weidner F
    Beitr Pathol; 1976 May; 157(3):269-82. PubMed ID: 1275868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.
    Urist MM; Balch CM; Soong S; Shaw HM; Milton GW; Maddox WA
    Cancer; 1985 Mar; 55(6):1398-402. PubMed ID: 3971310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma of the eyelid and periocular skin: Histopathologic classification and molecular pathology.
    Mancera N; Smalley KSM; Margo CE
    Surv Ophthalmol; 2019; 64(3):272-288. PubMed ID: 30578807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dubreuilh melanoma: and epidemiologic and prognostic study].
    Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
    Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of lentigo maligna and lentigo maligna melanoma.
    Pitman GH; Kopf AW; Bart RS; Casson PR
    J Dermatol Surg Oncol; 1979 Sep; 5(9):727-37. PubMed ID: 489814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.
    Bolshinsky V; Lin MJ; Serpell J; Leung M; Wolfe R; McLean C; Kelly JW
    J Am Acad Dermatol; 2016 Jan; 74(1):102-7. PubMed ID: 26601566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas.
    Lefevre M; Vergier B; Balme B; Thiebault R; Delaunay M; Thomas L; Beylot-Barry M; Machet L; De Muret A; Bioulac-Sage P; Bailly C
    Am J Surg Pathol; 2003 Jun; 27(6):717-24. PubMed ID: 12766575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1979 Mar; 87A(2):131-8. PubMed ID: 433595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma.
    Kelly JW; Sagebiel RW; Calderon W; Murillo L; Dakin RL; Blois MS
    Ann Surg; 1984 Dec; 200(6):759-63. PubMed ID: 6508406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.